Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.48 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
| ▸ | TK2 | O00142 | 2/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.41 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CDA | P32320 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3841360 | 1.00 | PYGM (0.48) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL27708288 | 0.88 | PYGM (0.60) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL27618439 | 0.87 | PYGM (0.46) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL27810485 | 0.86 | ADORA2A (0.39) | PYGMMAPT | |
| SCHEMBL27760732 | 0.86 | PYGM (0.51) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL1067013 | 0.85 | PYGM (0.52) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL1932437 | 0.83 | PYGM (0.50) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL21458099 | 0.83 | PYGM (0.52) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL441977 | 0.81 | PYGM (0.48) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL20534354 | 0.81 | PYGM (0.48) | PYGMSLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101341260-A | Multi-component nucleases and methods of use thereof | JOHNSON & JOHNSON RES PTY LTD (AU) | 2009-01-07 | — | — | CN | claimed |
| US-20240011084-A1 | METHODS FOR FULL-LENGTH REVERSE TRANSCRIPTION PCR OF LONG RNAs CONTAINING MODIFIED RIBONUCLEOSIDES USING A THERMOSTABLE REVERSE TRANSCRIPTASE | NORTHWESTERN UNIVERSITY | 2024-01-11 | — | — | US | disclosed |
| WO-2020033416-A1 | COMBINED TRANSCRIPTION AND TRANSLATION PLATFORM DERIVED FROM PLANT CHLOROPLASTS | NORTHWESTERN UNIVERSITY (US) | 2020-02-13 | — | — | WO | disclosed |
| CN-109793893-A | VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER | 达特茅斯大学理事会 | 2019-05-24 | — | — | CN | disclosed |
| CN-105246507-B | VISTA Modulators for Diagnosis and Treatment of Cancer | 达特茅斯大学理事会 | 2019-01-25 | — | — | CN | disclosed |
| CN-105246507-A | VISTA modulators for diagnosis and treatment of cancer | DARTMOUTH COLLEGE | 2016-01-13 | — | — | CN | disclosed |
| CN-104072611-A | Novel cancer-associated antigen | VIVENTIA BIOTECHNOLOGIES INC | 2014-10-01 | — | — | CN | disclosed |
| CN-104001158-A | Use of Bv8 and/or EG-VEGF to promote hematopoiesis | GENENTECH INC | 2014-08-27 | — | — | CN | disclosed |
| CN-102225194-B | Use of Bv8 and/or EG-VEGF to promote hematopoiesis | GENENTECH INC | 2014-07-16 | — | — | CN | disclosed |
| CN-102725424-B | Self-folding amplification of target nucleic acids | RD BIOSCIENCES INC | 2014-07-09 | — | — | CN | disclosed |
| CN-101076594-A | Arabidopsis coding genes for proteins involved in sugar and lipid metabolism and methods of use | BASF PLANT SCIENCE GMBH (DE) | 2007-11-21 | — | — | CN | disclosed |
| CN-1929833-A | Oxydecahydronaphthalene modulators of HM74 | AVENTIS PHARMA INC (US) | 2007-03-14 | — | — | CN | disclosed |
| CN-1921845-A | Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation | AVENTIS PHARMA INC (US) | 2007-02-28 | — | — | CN | disclosed |
| CN-1898263-A | Nucleic acids encoding novel prostaglandin receptor proteins and methods of use thereof | AVENTIS PHARMA INC (US) | 2007-01-17 | — | — | CN | disclosed |
| CN-1898389-A | Modulators of sugar and lipid metabolism in plants VI | BASF PLANT SCIENCE GMBH (DE) | 2007-01-17 | — | — | CN | disclosed |
| CN-1809588-A | Novel methods for modulating bone-related activity | WYETH CORP (US) | 2006-07-26 | — | — | CN | disclosed |
| CN-1802169-A | Use of bv8 and/or EG-VEGF to promote hematopoiesis | GENENTECH INC (US) | 2006-07-12 | — | — | CN | disclosed |
| CN-1575338-A | Bv8 nucleic acids and polypeptides having mitogenic activity | GENENTECH INC (US) | 2005-02-02 | — | — | CN | disclosed |
| CN-1547483-A | New use of ARTEMIN, a member of the GDNF ligand family | �����ɷ� | 2004-11-17 | — | — | CN | disclosed |
| CN-1347460-A | Monolayer and electrode for detecting label-bearing target and method of use thereof | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2002-05-01 | — | — | CN | disclosed |